Processa Pharmaceuticals Issues Letter to Shareholders
HANOVER, MD, Nov. 29, 2023 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage...
Source: globenewswire.com
Stay updated with breaking news from Processa Pharmaceuticals Shareholders. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
HANOVER, MD, Nov. 29, 2023 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage...